Home » Topics » BioWorld Science

BioWorld Science
RSS

Takeda develops potassium channel openers for cardiovascular indications

Nov. 26, 1997

New agents for heart disease prepared by Dainippon Ink & Chemicals

Nov. 26, 1997

Milestone reached in antiinfectives alliance

Nov. 26, 1997

ProLease hGH slated to enter phase III

Nov. 26, 1997

ImmuLogic restructures its operations

Nov. 26, 1997

Sertoli and Carolinas Medical Center collaborate to develop novel diabetes therapy

Nov. 26, 1997

NINDS study links herpesvirus strain to MS

Nov. 26, 1997

Results from Leuvectin trial in kidney cancer patients reported

Nov. 26, 1997

Preliminary results reported for IL-2 gene therapy in GI cancer

Nov. 26, 1997

Positive phase I/II results reported for adenoviral p53 gene therapy

Nov. 26, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 12, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...